Shine-on Biomedical Co., Ltd.

This study tests a new drug called SOA101, a special antibody that can attach to both cancer cells and immune cells to help the immune system attack tumors. It is for people with advanced solid tumors (like lung, ovarian, or breast cancer) who have no other standard treatment opt…

This early-phase trial tests a new drug called SOB100, which uses tiny particles called exosomes to target a protein named HLA-G. The study involves 15 healthy adults to check if the drug is safe and how the body processes it. No treatment benefit is expected; the goal is to gath…